Nervous System Lupus: Pathogenesis and Rationale for Therapy

References

• Kaposi M K. Neue Beitrage zur Kenntniss des lupus eryth-ematosus. Arch Dermatol Syphilol 1872; 4: 36–78
   Google Scholar
• Denburg J A, Temesvari P. The pathogenesis of neuropsychi-atric lupus. Can Med Assoc J 1983; 128: 257–60
   PubMed Web of Science ®Google Scholar
• Asherson R A, Denburg S D, Denburg J A, Carbotte R M, Futrell N. Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE). Postgrad Med J 1993; 69: 602–8
   PubMedGoogle Scholar
• Denburg J A, Carbotte R, Denburg S. Central nervous system lupus. Rheumatology Review 1993; 2: 123–32
   Google Scholar
• Denburg J A. Clinical and subclinical involvement of the central nervous system in systemic lupus erythematosus. Immunologic Mechanisms in Neurologic and Psychiatric Disease, B H Waksman. Raven Press, Ltd, New York 1990; 171–8
   Google Scholar
• Bombardier C, Gladman D D, Urowitz M B, Caron D, Chang C H. the Committee on prognosis studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–40
   PubMed Web of Science ®Google Scholar
• Liang M H, Socher S A, Larson M G, Schur P H. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107–18
   PubMed Web of Science ®Google Scholar
• Urowitz M B, Gladman D D, Tozman E CS, Goldsmith C H. The lupus activity criteria count (LACC). J Rheumatol 1984; 11: 783–7
   PubMed Web of Science ®Google Scholar
• Bluestein H G. The central nervous system in systemic lupus erythematosus. Systemic Lupus Erythematosus. 2nd ed., R G Lahita. Churchill Livingstone, New York 1992; 639–55
   Google Scholar
• West S G. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994; 20: 129–58
   PubMed Web of Science ®Google Scholar
• Carbotte R M, Denburg S D, Denburg J A. Cognitive dysfunction and systemic lupus erythematosus. Systemic Lupus Erythematosus. 2nd ed., R G Lahita. Churchill Livingstone, New York 1992; 86: 5–81
   Google Scholar
• Denburg S D, Denburg J A, Carbotte R M, Fisk J D, Hanly J G. Cognitive deficits in systemic lupus erythematosus. Rheum Dis Clin North Am 1993; 19: 81-5–31
   Google Scholar
• Denburg S D, Carbotte R M, Denburg J A. Mental dysfunction in systemic lupus erythematosus, J H Klippel, P A Dieppe. St. Louis; Mosby, Rheumatology 1994; 7.8–7.10
   Google Scholar
• Carbotte R M, Denburg S D, Denburg J A. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986; 174: 357–64
   PubMed Web of Science ®Google Scholar
• Denburg S D, Carbotte R M, Denburg J A. Cognitive impairment in systemic lupus erythematosus: A neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 1987; 9: 323–39
   PubMed Web of Science ®Google Scholar
• Hay E M, Black D, Huddy A, Creed F, Tomenson B, Bernstein R M, et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 411–6
   PubMed Web of Science ®Google Scholar
• Hanly J G, Fisk J D, Shenvood G, Jones E, Jones J V, Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 562–7
   PubMedGoogle Scholar
• Ginsburg K S, Wright E A, Larson M G, Fossel A H, Albert M, Schur P H, et al. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 1992; 35: 776–82
   PubMed Web of Science ®Google Scholar
• Kutner K C, Busch H M, Mahmood T, Racis S P, Krey P R. Neuropsychological functioning in systemic lupus erythematosus. Neuropsychology 1988; 2: 119–26
   Google Scholar
• Sakic B, Szechtman H, Keffer M, Talangbayan H, Stead R, Denburg J A. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav Immun 1992; 6: 265–85
   PubMedGoogle Scholar
• Sakic B, Szechtman H, Talangbayan H, Denburg S D, Carbotte R M, Denburg J A. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol Behav 1994; 56: 609–17
   PubMed Web of Science ®Google Scholar
• Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069–73
   PubMed Web of Science ®Google Scholar
• Sakic B, Szechtman H, Talangbayan H, Denburg S, Carbotte R, Denburg J A. Behavior and immune status of MRL mice in the postweaning period. Brain Behav Immun 1994; 8: 1–13
   PubMed Web of Science ®Google Scholar
• Sakic B, Szechtman H, Denburg S, Carbotte R, Denburg J A. Spatial learning during the course of autoimmune disease in MRL mice. Behav Brain Res 1993; 54: 57–66
   PubMedGoogle Scholar
• Sakic B S, Szechtman H, Denburg S D, Carbotte R M, Denburg J A. Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice. Physiol Behav 1993; 54: 1025–9
   PubMedGoogle Scholar
• Bluestein H G, Zvaifler N J. Brain-reactive lymphocyto toxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest 1976; 57: 509–16
   PubMed Web of Science ®Google Scholar
• Denburg J A, Carbotte R M, Denburg S D. Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 1987; 37: 464–7
   PubMed Web of Science ®Google Scholar
• Denburg S D, Carbotte R M, Long A A, Denburg J A. Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus. Brain Behav Immun 1988; 2: 222–34
   PubMedGoogle Scholar
• How A, Dent P B, Liao S K, Denburg J A. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1985; 28: 789–95
   PubMed Web of Science ®Google Scholar
• Hanly J G, Behmann S, Denburg S D, Carbotte R M, Denburg J A. The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus. Postgrad Med J 1989; 65: 622–7
   PubMedGoogle Scholar
• Bluestein H G. Autoantibodies to lymphocyte membrane antigens: pathogenetic implications. Clin Rheum Dis 1978; 4: 643–59
   Google Scholar
• Bluestein H G, Williams G W, Steinberg A D. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 1981; 70: 240–6
   PubMed Web of Science ®Google Scholar
• Bresnihan B, Grigor R R, Hughes G RV. Lymphocytotoxic antibodies in systemic lupus erythematosus: their clinical significance. J Clin Pathol 1979; 13: 112–5
   Google Scholar
• Bresnihan B, Oliver M, Grigor R, Hughes G RV. Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol 1977; 30: 333–7
   PubMedGoogle Scholar
• Kelly M C, Denburg J A. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions. J Rheumatol 1987; 14: 740–4
   PubMedGoogle Scholar
• Long A A, Denburg S D, Carbotte R M, Singal D P, Denburg J A. Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis 1990; 49: 249–53
   PubMed Web of Science ®Google Scholar
• Papero P H, Bluestein H G, White P, Lipnick R N. Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus. Clin Exp Rheumatol 1990; 8: 417–24
   PubMed Web of Science ®Google Scholar
• Temesvari P, Denburg J, Denburg S, Carbotte R, Bensen W, Singal D. Serum lymphocytotoxic antibodies in neuropsychiatric lupus: a serial study. Clin Immunol Immunopathol 1983; 28: 243–51
   PubMedGoogle Scholar
• Winfield J B. Anti-lymphocyte antibodies in systemic lupus erythematosis. Clin Rheum Dis 1985; 11: 523–49
   PubMedGoogle Scholar
• Bluestein H G, Woods V LJ. Antineuronal antibodies in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 773–8
   PubMedGoogle Scholar
• Butler W T, Sharp J T, Rossen R D, Lidsky M D, Mittal K K, Gard D A. Relationship of the clinical course of systemic lupus erythematosus to the presence of circulating lymphocy-totoxic antibodies. Arthritis Rheum 1972; 15: 251–8
   PubMedGoogle Scholar
• Williams G W, Bluestein H G, Steinberg A D. Brain-reactive lymphocytotoxic antibody in the cerebrospinal fluid of patients with systemic lupus erythematosus: correlation with central nervous system involvement. Clin Immunol Immunopathol 1981; 18: 126–32
   PubMedGoogle Scholar
• Denburg S D, Behmann S A, Carbotte R M, Denburg J A. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus: Relationship of lymphocyte antibody specificities to clinical disease. Arthritis Rheum 1994; 37: 369–75
   PubMedGoogle Scholar
• Kopelman R G, Zolla-Pozner S.Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988; 84: 82–8
   PubMed Web of Science ®Google Scholar
• Price R W, Brew B. Infection of the central nervous system by human immunodeficiency virus: role of the immune system in pathogenesis. Ann N Y Acad Sci 1988; 540: 162–75
   PubMedGoogle Scholar
• Rodgers-Johnson P EB, Ono S G, Asher D M, Gibbs C J. Tropical spastic paraparesis and HTLV-1 myelopathy: clinical features and pathogenesis. Immunologic Mechanisms in Neurologic and Psychiatric Disease, B H Waksman. Raven Press, New York 1990; 117–30
   Google Scholar
• Ziegler J L, Stites D P. Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol 1986; 41: 305–13
   PubMedGoogle Scholar
• Kion T A, Hoffmann G W. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science 1991; 253: 1138–40
   PubMed Web of Science ®Google Scholar
• Tyor W R, Glass J D, Griffin J W, Becker P S, McArthur J C, Bezman L, et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992; 31: 349–60
   PubMed Web of Science ®Google Scholar
• McGarry R C, Helfand S L, Quarles R H, Roder J C. Recognition of myelin-associated glycoprotein by the monoclonal antibody, HNK-1. Nature 1983; 306: 376–8
   PubMedGoogle Scholar
• Latov H, Sherman W H, Nemni R, Galassi G, Shyong J S, Penn A S, et al. Plasma cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral nerve myelin. N Engl J Med 1980; 303: 618–21
   PubMed Web of Science ®Google Scholar
• Bottazzo G F, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet 1983; 11: 1115–9
   Google Scholar
• Harris E N, Gharavi A E, Mackworth-Young C G, Patel B M, Derue G, Hughes G RV. Lupoid sclerosis: a possible patho-genetic role for antiphospholipid antibodies. Ann Rheum Dis 1985; 44: 281–3
   PubMedGoogle Scholar
• Waksman B H. Autoimmunity in demyelinating diseases. Ann N Y Acad Sci 1988; 540: 13–24
   PubMedGoogle Scholar
• Powell M B, Steinman L. The role of lymphotoxin and TNF in demyelinating diseases of the CNS. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, B Bentler. Raven Press, New York 1992; 355–69
   Google Scholar
• Carbotte R M, Denburg S D, Denburg J A, Nahmias C, Garnett E S. Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1992; 55: 1054–9
   PubMed Web of Science ®Google Scholar
• Awada H H, Mamo H L, Luft A G, Ponsin J C, Kahn M F. Cerebral blood flow in systemic lupus with and without central nervous system involvement. J Neurol Neurosurg Psychiatry 1987; 50: 1597–601
   PubMedGoogle Scholar
• Bell C L, Partington C, Robbins M, Graziano F, Turski P, Kornguth S. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus: correlation with clinical remission and antineurofilament and anticar-diolipin antibody titers. Arthritis Rheum 1991; 34: 432–41
   PubMedGoogle Scholar
• Hiraiwa M, Nonaka C, Abe T, Iio M. Positron emission tomography in systemic lupus erythematosus: relation of cerebral vasculitis to PET findings. AJNR 1983; 4: 541–3
   PubMedGoogle Scholar
• Kushner M J, Chawluk M D, Fazekas F, Burke A, Jagg J, Rosen M, et al. Cerebral blood flow in systemic lupus erythematosus with or without cerebral complications. Neurology 1987; 37: 1596–8
   PubMedGoogle Scholar
• McCune W J, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988; 31: 159–66
   PubMedGoogle Scholar
• Pinching A J, Travers R L, Hughes G RV, Jones T, Moss S. Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet 1978; 1: 898–900
   PubMed Web of Science ®Google Scholar
• Sibbitt W L, Sibbitt R R, Griffey R H, Eckel C, Bankhurst A D. Magnetic resonance imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 1014–22
   PubMed Web of Science ®Google Scholar
• Stoppe G, Wildhagen K, Seidel J W, Meyer G J, Schober O, Heintz P, et al. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 1990; 40: 304–8
   PubMed Web of Science ®Google Scholar
• Pawlik G, Heiss W D. Positron emission tomography and neuropsychological function. Neuropsychological Function and Brain Imaging, E D Bigler, R A Yeo, E Turkheimer. Plenum Press, New York 1989; 65–137
   Google Scholar
• Ritchlin C T, Chabot R J, Alper K, Buyon J, Belmont H M, Roubey R, et al. Quantitative electroencephalography: A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 1330–42
   PubMedGoogle Scholar
• Bennahum D A, Messner R P, Shoop J D. Brain scan findings in central nervous system involvement by lupus erythematosus. Ann Intern Med 1974; 81: 763–5
   PubMedGoogle Scholar
• Vermess M, Bernstein R M, Bydder G M, Steiner R E, Young I R, Hughes G RV. Nuclear magnetic resonance (NMR) imaging of the brain in systemic lupus erythematosus. J Comput Assist Tomogr 1983; 7: 461–7
   PubMed Web of Science ®Google Scholar
• Billingsley L M, Yannakakis G D, Stevens M B. Evoked potentials (EPs): a sensitive test for CNS-SLE (abstract). Arthritis Rheum 1985; 28: S22
   Google Scholar
• Nossent J C, Hovestadt A, Schonfeld D H, Swaak A J. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum 1991; 34: 1397–403
   PubMedGoogle Scholar
• Carette S, Urowitz M B, Grossman H, St. Louis E L. Cranial computerized tomography in systemic lupus erythematosus. J Rheumatol 1982; 9: 855–9
   PubMedGoogle Scholar
• Jankovic B D, Rakic L, Veskov R, Horvat J. Effect of intraventricular injection of anti-brain antibody on defensive conditioned reflexes. Nature 1968; 218: 270–1
   PubMed Web of Science ®Google Scholar
• Karpiak S E, Graf L, Rapport M M. Antiserum to brain gangliosides produces recurrent epileptiform activity. Science 1976; 194: 735–7
   PubMed Web of Science ®Google Scholar
• Simon J, Simon O. Effect of passive transfer of anti-brain antibodies to a normal recipient. Exp Neurol 1975; 47: 523–34
   PubMedGoogle Scholar
• Brey R L, Cote S A, Holliday S L, Teale J M. Central nervous system (CNS) dysfunction is accelerated in lupus mice immunized with neuronal surface proteins (abstract). Lupus 1995; 4 (suppl 2): 50
   Google Scholar
• Endo T, Scott D D, Stewart S S, Kundu S K, Marcus D M. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol 1984; 132: 1793–7
   PubMedGoogle Scholar
• Minota S, Winfield J B. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus. J Immunol 1987; 139: 3644–51
   PubMed Web of Science ®Google Scholar
• Minota S, Winfield J B. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line. J Immunol 1987; 138: 1750–6
   PubMedGoogle Scholar
• Schneebaum A B, Singleton J D, West S G, Blodgett J K, Allen L G, Cheronis J C, et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991; 90: 54–62
   PubMed Web of Science ®Google Scholar
• Bonfa E, Golombek S J, Kaufman L D, Skelly S, Weissbach H, Brot N, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317: 265–71
   PubMed Web of Science ®Google Scholar
• Hanly J G, Hong C. Antibodies to brain integral membrane proteins in systemic lupus erythematosus. J Immunol Methods 1993; 161: 107–18
   PubMedGoogle Scholar
• Robbins M L, Kornguth S E, Bell C L, Kalinke T, England D, Turski P, et al. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus: Combination with anticardiolipin antibody assay and magnetic resonance imaging. Arthritis Rheum 1988; 31: 623–31
   PubMed Web of Science ®Google Scholar
• Hirano T, Hashimoto H, Shiokawa Y, Iwamori M, Nagai Y, Kasai M, et al. Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. J Clin Invest 1980; 66: 1437–40
   PubMedGoogle Scholar
• Teplizki H, Buskila D, Argov S, Isenberg D A, Coates A RM, Sukenik S, et al. Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement. J Rheumatol 1987; 14: 507–11
   PubMedGoogle Scholar
• Pischel K D, Bluestein H G, Woods V LJ. Platelet glycoproteins Ia, Ic, and IIa are physicochemically indistinguishable from the very late activation antigens adhesion-related proteins of lymphocytes and other cell types. J Clin Invest 1988; 81: 505–13
   PubMed Web of Science ®Google Scholar
• Denburg J A, Behmann S A. Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kd reactivity. Ann Rheum Dis 1994; 53: 304–8
   PubMed Web of Science ®Google Scholar
• Hanson V G, Horowitz M, Rosenbluth D, Spiera H, Puszkin S. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. J Exp Med 1992; 176: 565–73
   PubMedGoogle Scholar
• Teh L S, Isenberg D A. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal. Arthritis Rheum 1994; 37: 307–15
   PubMedGoogle Scholar
• Koren E, Reichlin M W, Koscec M, Fugate R D, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992; 89: 1236–41
   PubMedGoogle Scholar
• Ziporen L, Shoenfeld Y, Korzcyn A. Neurological dysfunctions associated with anti-phospholipid antibodies (aPL) (abstract). Lupus 1995; 4 (suppl 2): 49
   Google Scholar
• Moore P M. Isolation and characterization of a brain autoan-tigen in NP-SLE (abstract). Lupus 1995; 4 (suppl 2): 53
   Google Scholar
• Moore P M, Joshi I, Ghanekar S A. Affinity isolation of neuron-reactive antibodies in MRL/lpr mice. J Neurosci Res 1994; 39: 140–7
   PubMedGoogle Scholar
• Aron A L, Cuellar M L, Brey R L, Gharavi A E. Antiphospholipid syndrome in MRL/+ + mice following immunization with b2 GPI (abstract). Lupus 1995; 4((suppl 2))20
   Google Scholar
• Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990; 17: 34–7
   PubMedGoogle Scholar
• Fields R A, Sibbitt W L, Toubbeh H, Bankhurst A D. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. Ann Rheum Dis 1990; 49: 114–7
   PubMed Web of Science ®Google Scholar
• Long A A, Ginsberg J S, Brill-Edwards P, Johnston M, Turner C, Denburg J A, et al. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 1991; 66: 520–4
   PubMed Web of Science ®Google Scholar
• Mosmann T R, Moore K W. The role of IL-10 in crossregul-ation of TH1 and TH2 responses. Immunol Today 1991; 12: A 49–53
   Google Scholar
• Stevens T L, Bossie A, Sanders V M, Fernandez-Botran R, Coffman R L, Mosmann T R, et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988; 334: 255–8
   PubMed Web of Science ®Google Scholar
• Merrill J E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 1992; 14: 1–10
   PubMed Web of Science ®Google Scholar
• Merrill J E, Chen I S. HIV-I, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 1991; 5: 2391–7
   PubMed Web of Science ®Google Scholar
• Merrill J E, Koyanagi Y, Zack J, Thomas L, Martin F, Chen I SY. Induction of interleukin-I and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type l. J Virol 1992; 66: 2217–25
   PubMed Web of Science ®Google Scholar
• Merrill J E, Kono D H, Clayton J, Ando D G, Hinton D R, Hofman F M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomy-elitis in SJL and BIO.PL mice. Proc Natl Acad Sci USA 1992; 89: 574–8
   PubMed Web of Science ®Google Scholar
• Chung I Y, Benveniste E N. Tumor necrosis factor-a production by astrocytes: Induction by lipopolysaccharide, IFN-α and IL-1 beta. J Immunol 1990; 144: 2999–3007
   PubMed Web of Science ®Google Scholar
• Breder C D, Dinarello C A, Saper C B. Interleukin-I immuno-reactive innervation of the human hypothalamus. Science 1988; 240: 321–4
   PubMed Web of Science ®Google Scholar
• Yan H Q, Banos M A, Herregodts P, Hooghe R, Hooghe-Peters E L. Expression of interleukin (IL)-lβ, IL-6 and their respective receptors in the normal rat brain and after injury. Eur J Immunol 1992; 22: 2963–71
   PubMed Web of Science ®Google Scholar
• Plata-Salaman C R. Immunoregulators in the nervous system. Neurosci Behav Rev 1991; 15: 185–215
   PubMed Web of Science ®Google Scholar
• Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16: 39–43
   PubMedGoogle Scholar
• Ohteki T, Okamoto S, Nakamura M, Nemoto E, Kumagai K. Elevated production of interleukin 6 by hepatic MNC correlates with ICAM-1 expression on the hepatic sinusoidal endothelial cells in autoimmune MRL/lpr mice. Immunol Lett 1993; 36: 145–52
   PubMedGoogle Scholar
• Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T, et al. Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 1991; 3: 273–8
   PubMed Web of Science ®Google Scholar
• Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum 1992; 35: 417–22
   PubMed Web of Science ®Google Scholar
• Boswell J M, Yui M A, Burt D W, Kelley V E. Increased tumor necrosis factor and IL-lb gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988; 141: 3050–4
   PubMed Web of Science ®Google Scholar
• Yui M A, Brissette W J, Brennan D C, Wuthrich R P, Rubin-Kelley V E. Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice. Am J Pathol 1991; 139: 255–61
   PubMed Web of Science ®Google Scholar
• Levine J S, Puch B J, Hartwell D, Fitzpatrick J M, Marshak-Rothstein A, Beller D I. Interleukin-I dysregulation is an intrinsic defect in macrophages from MRL autoimmune-prone mice. Eur J Immunol 1993; 23: 2951–8
   PubMedGoogle Scholar
• Houssiau F A, Devogelaer J P, Van Damme J, Nagant de Deuxchaisnes C, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988; 31: 784–8
   PubMed Web of Science ®Google Scholar
• Houssiau F A, Bukasa K, Sindic C JM, Van Damme J, Van Snick J. Elevated levels of the 26 K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol 1988; 71: 320–3
   PubMed Web of Science ®Google Scholar
• Hirohata S, Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus eryth-ematosus and central nervous system involvement. Arthritis Rheum 1990; 33: 644–9
   PubMed Web of Science ®Google Scholar
• Frei K, Leist T P, Meager A, Gallo P, Leppert D, Zinkernagel R M, et al. Production of B cell stimulatory factor-2 and interferon t in the central nervous system during viral meningitis and encephalitis: evaluation in a murine model infection and in patients. J Exp Med 1988; 168: 449–53
   PubMed Web of Science ®Google Scholar
• Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin 6, interleukin l, and fatal outcome. J Exp Med 1989; 169: 333–8
   PubMed Web of Science ®Google Scholar
• Jacob C O, McDevitt H O. Tumour necrosis factor-α in murine autoimmune ‘lupus’ nephritis. Nature 1988; 331: 356–8
   PubMed Web of Science ®Google Scholar
• Sherman G F, Morrison L, Rosen G D, Behan P O, Galaburda A M. Brain abnormalities in immune defective mice. Brain Res 1990; 532: 25–33
   PubMedGoogle Scholar
• Sherman G F, Stone J S, Rosen G D, Galaburda A M. Neocortical VIP neurons are increased in the hemisphere containing focal cerebrocortical microdysgenesis in New Zealand Black mice. Brain Res 1990; 532: 232–6
   PubMedGoogle Scholar
• Schrott L M, Denenberg V H, Sherman G F, Waters N S, Rosen G D, Galaburda A M. Environmental enrichment, neocortical ectopias, and behavior in the autoimmune NZB mouse. Brain Res Dev Brain Res 1992; 67: 85–93
   PubMedGoogle Scholar
• Denenberg V H, Sherman G F, Morrison L, Schrott L M, Waters N S, Rosen G D, et al. Behavior, ectopias and immunity in BD/DB reciprocal crosses. Brain Res 1992; 571: 323–9
   PubMedGoogle Scholar
• Denenberg V H, Mobraaten L E, Sherman G F, Morrison L, Schrott L M, Waters N S, et al. Effects of the autoimmune uterine/maternal environment upon cortical ectopias, behavior and autoimmunity. Brain Res 1991; 563: 114–22
   PubMedGoogle Scholar
• Sakic B, Szechtman H, Denburg J A. Depressive-like behavior in an animal model of lupus (abstract). Lupus 1995; 4((suppl 2))76
   Google Scholar
• Szechtman H, Denburg J A, Sakic B. Neurobehavioral dysfunction in lupus-prone MRL mice (abstract). Lupus 1995; 4((suppl 2))52
   Google Scholar
• Vogelweid C M, Johnson G C, Besch-Williford C L, Basler J, Walker S E. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J Neuroimmunol 1991; 35: 89–99
   PubMedGoogle Scholar
• Denburg J A, Denburg S D, Carbotte R M, Sakic B, Szechtman H. Immune and inflammatory mechanisms in CNS lupus: Rationale for therapy (abstract). Lupus 1995; 4((suppl 2))51
   PubMedGoogle Scholar
• Ellis S G, Verity M A. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979; 8: 212–21
   PubMed Web of Science ®Google Scholar
• Johnson R T, Richardson E P. The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine (Baltimore) 1968; 47: 337–69
   PubMed Web of Science ®Google Scholar
• Hanly J G, Walsh N M, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992; 19: 732–41
   PubMed Web of Science ®Google Scholar
• Sakic B, Szechtman H, Denburg S D, Denburg J A. Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice. Physiol Behav 1995; 58: 797–802
   PubMedGoogle Scholar
• Sergent J S, Lockshin M D, Klempner M S, Lipsky B A. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am J Med 1975; 58: 644–54
   PubMed Web of Science ®Google Scholar
• Hirohata S, Iwamoto S, Miyamoto T, Sugiyama H, Nakano K, Inokuma S. A patient with systemic lupus erythematosus presenting both central nervous system lupus and steroid induced psychosis. J Rheumatol 1988; 15: 706–10
   PubMedGoogle Scholar
• Perry P J, Tsuang M T, Hwang M H. Prednisolone psychosis: clinical observation. Drug Intell Clin Pharm 1984; 18: 603–9
   PubMedGoogle Scholar
• Ling M HM, Perry P H, Tsuang M T. Psychiatric side effects of corticosteroid therapy. Arch Gen Psychiatry 1981; 38: 471–7
   PubMed Web of Science ®Google Scholar
• Denburg S D, Carbotte R M, Denburg J A. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1311–20
   PubMedGoogle Scholar
• Asherson R A, Khamashta M A, Gil A, Vazquez J J, Chan O, Baguley E, et al. Cerebrovascular disease and antiphospho-lipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989; 86: 391–9
   PubMed Web of Science ®Google Scholar
• Ginsberg J S, Brill-Edwards P, Johnston M, Denburg J A, Andrew M, Burrows R, et al. The relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: A cross-sectional study. Blood 1992; 80: 975–80
   PubMed Web of Science ®Google Scholar
• Ginsberg J S, Demers C, Brill-Edwards P, Bona R, Johnston M, Wong A, et al. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med 1995; 98: 379–83
   PubMedGoogle Scholar
• Love P E, Santoro S A. Antiphospholipid antibodies: anticar-diolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 682–98
   PubMed Web of Science ®Google Scholar
• Mackworth-Young C. Antiphospholipid antibodies: more than just a disease marker?. Immunol Today 1990; 11: 60–5
   PubMedGoogle Scholar
• Wang Y, Schrieber L, Cohen M G, Furphy L, Webb J, Chivers T, et al. Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients. Rheumatol Int 1990; 10: 75–80
   PubMedGoogle Scholar
• Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992; 89: 1558–63
   PubMed Web of Science ®Google Scholar
• Feinstein D I. Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. Blood 1992; 80: 859–62
   PubMedGoogle Scholar
• Khamashta M A, Cuadrado M J, Mujic F, Taub N A, Hunt B J, Hughes G RV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993–7
   PubMed Web of Science ®Google Scholar
• Lockshin M D. Answers to the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 1025–7
   PubMed Web of Science ®Google Scholar
• Carbotte R M, Denburg S D, Denburg J A. Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatol 1995; 22: 863–7
   PubMedGoogle Scholar
• Glanz B, Slonim D, Gladman D, Urowitz M, Heslegrave R, Darby P, et al. Patterns of neurocognitive dysfunction in inactive systemic lupus erythematosus (abstract). Lupus 1995; 4 (suppl 2): 52
   Google Scholar
• Arnon G, Carasso R, Dolev E, Yehuda S. Cognitive subclin-ical deficits in S.L.E. patients taking into account hemispheric dominance and sex (abstract). Lupus 1995; 4 (suppl 2): 71
   Google Scholar
• Fantini F, Limonta M, Masserini C, Barlocco A, Zeni S. Evaluation of cognitive dysfunction in patients with juvenile onset SLE (abstract). Lupus 1995; 4 (suppl 2): 73
   Google Scholar
• Thieme K, Gromnica-Ihle E. Neuropsychological impairment in SLE (abstract). Lupus 1995; 4 (suppl 2): 77
   Google Scholar
• Von Feldt J M, Zeit B, Bulbul R, Callegari P E, Gur R. A new brief cognitive screen in systemic lupus erythematosus (SLE): correlation with formal neuropsychiatric testing (abstract). Arthritis Rheum 1994; 37: S178
   Google Scholar
• Denburg S D, Carbotte R M, Denburg J A. Cognitive correlates of anti-phospholipid antibody positivity in SLE (abstract). Arthritis Rheum 1993; 36: S103
   Google Scholar
• Jacobs L, Salazar A M, Herndon R, Reese P A, Freeman A, Josefowicz R, et al. Multicentre double-blind study of effect of intrathecally administered natural human fibroblast inter-feron on exacerbations of multiple sclerosis. Lancet 1986; 11: 1411–3
   Google Scholar